About Esentra 120 Denosumab Solution Injection
Essentra 120 mg Injection
Essentra 120 contains an active immunosuppressive/chemotherapy-supportive agent (please ensure specification per exact molecule) used in clinical oncology settings. It is intended for patients requiring supportive or therapeutic interventions as per the prescribing oncologists guidance.
Key Uses:
-
As part of cancer treatment regimes (where indicated)
-
Supportive therapy in chemotherapy protocols
-
Management of immunosuppression / adjunct therapy as per physicians protocol
How It Works:
Essentra 120 works by modulating immune response or supporting therapy in oncology regimens, aiding in the effective treatment of cancer under specialist supervision.
Key Benefits:
-
Provides essential support during cancer therapy
-
Helps stabilize patient condition under treatment protocols
-
Manufactured under strict quality standards
Dosage & Administration:
-
Administer under the supervision of a qualified oncologist.
-
Dosage varies as per treatment protocol, patients condition, and clinical judgement.
Storage:
-
Store in recommended conditions (as per manufacturers guidelines).
-
Protect from moisture, heat, and direct light.
Why Choose Us:
-
100% genuine and quality-assured oncology medicine
-
Competitive pricing for wholesale & retail orders
-
Safe packaging and prompt delivery
-
Trusted supplier of specialty cancer medications
How to Use Esentra 120 Denosumab InjectionEsentra 120 is for subcutaneous use only and should be administered by a healthcare professional. Before starting, ensure that serum calcium, phosphorus, and magnesium levels are within normal ranges. The vial is for single use and should be disposed of after one dose. Do not shake the vial, and always inspect the solution, ensuring it is clear to slightly opalescent and colorless to pale yellow. Adherence to proper injection technique and aseptic precautions is essential.
Key Benefits of Esentra 120Esentra 120 delivers targeted therapy for patients with bone complications related to oncology, such as bone metastases and giant cell tumor of bone. Its mechanism helps prevent skeletal-related events including fractures or spinal cord compression. As a monoclonal antibody, it specifically inhibits bone resorption to maintain or improve bone strength and structure. By mitigating bone complications, Esentra 120 supports better patient quality of life in cancer care.
Proper Storage and Shelf LifeStore Esentra 120 in a refrigerator at 2C - 8C. Avoid freezing and keep the vial protected from light. Adhere to the storage instructions on the packaging and always check the expiry date before administration. Proper storage is crucial to maintain the medication's efficacy and safety throughout its 24-month shelf life. Do not use if the solution appears cloudy or contains particles.
FAQ's of Esentra 120 Denosumab Solution Injection:
Q: How should Esentra 120 Denosumab Solution Injection be administered?
A: Esentra 120 is intended for subcutaneous injection only and must be administered by a healthcare professional. The entire contents of the single-use vial are injected in one dose, typically in locations such as the upper arm, thigh, or abdomen. Do not inject intravenously or intramuscularly.
Q: What should I do to prepare before receiving this injection?
A: Before receiving Esentra 120, your healthcare provider will ensure your blood calcium, phosphorus, and magnesium levels are adequate. You may be advised to take calcium and vitamin D supplements to reduce the risk of low calcium levels during treatment.
Q: When is Esentra 120 contraindicated?
A: Esentra 120 should not be used if you have hypocalcemia or are hypersensitive to Denosumab or any of its ingredients. Your medical history will be assessed prior to starting therapy to prevent adverse reactions.
Q: Where should Esentra 120 be stored before use?
A: Store Esentra 120 in a refrigerator at a temperature between 2C and 8C. Do not freeze the vial, and keep it protected from light within its original carton. Dispose of after single use.
Q: What is the primary benefit of using Esentra 120 for patients with bone disorders?
A: Esentra 120 is a targeted antiresorptive therapy designed to reduce bone complications in adults with bone metastases from solid tumors or giant cell tumors. It works by inhibiting bone breakdown, thus lowering the risk of skeletal-related events such as fractures.
Q: How often should Esentra 120 be administered?
A: The frequency of administration depends on your physician's regimen, which is guided by your medical condition and response to therapy. Do not self-administer; always follow your doctor's instructions regarding dosing intervals.